Table 1 Baseline patient characteristics.

From: Robot therapy aids mental health in patients with hematological malignancy during hematopoietic stem cell transplantation in a protective isolation unit

SCT

SCT-A

SCT-C

p-value

Number of patients

11

10

 

Age median (range)

48

57

N.S

 

(24–65)

(44–67)

Sex

 Male

4

7

N.S

 Female

7

3

Diagnosis

 AL

6

4

N.S

 MDS

4

2

 Others#

1

4

Disease status at administration in PIU

 CR1-2

5

7

N.S

 NonCR

6

3

SCT

 RIST

10

6

N.S

 ASCT

1

4

Disease status at discharge from PIU

 CR

10

10

N.S

 NonCR

1

0

PIU duration (days) median(range)

61

46

N.S

(21–109)

(24–88)

  1. #Others included NHL and MM. AL: acute leukemia, ASCT: autologous stem cell transplant, CBT: umbilical cord blood transplant, CR: complete response, Chemo-A: chemotherapy with aibo, Chemo-C: chemotherapy as control, MDS: myelodysplastic syndrome, MM: multiple myeloma, NHL: non Hodgkin lymphoma, PIU: protective isolation unit. RIST: reduced-intensity conditioning stem cell transplant, SCT-A: stem cell transplant with aibo, SCT-C: stem cell transplant as control, SCT: stem cell transplant.
Back to article page